A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid Tumors

By sjmartinez • March 27, 2025

Eng C, Lakhani NJ, Philip PA, Schneider C, Johnson B, Kardosh A, Chao MP, Patnaik A, Shihadeh F, Lee Y, Song K, Jin D, Huo Y, Howland M, Fisher GA, Hecht JR. A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid Tumors. Target Oncol. 2025 Mar 26. doi: 10.1007/s11523-025-01130-y. Epub ahead of print. PMID: 40140179.

Tags: Hematology/Oncology, Publications

Oncofertility patterns after the overturn of Roe v. Wade

Baclig NV, Silverstein J, Shah V, Karlan B, Anand SR, Glaspy JA. Oncofertility patterns after the overturn of Roe v. Wade. J Natl Cancer Inst.[...]

Safety First

Moghanaki D, Gower A. Safety First. Int J Radiat Oncol Biol Phys. 2026 May 1;125(1):18. doi: 10.1016/j.ijrobp.2025.12.009. PMID: 42000358.

Personalizing Curative Therapy in Stage II to III Triple-Negative Breast Cancer

LeVee A, Hennessy MA, Idossa D, Leon-Ferre RA, Nanda R, McArthur H. Personalizing Curative Therapy in Stage II to III Triple-Negative Breast Cancer. Am Soc[...]